Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenetic Biosciences Inc

2.79
+0.09743.61%
Post-market: 2.860.0676+2.42%16:00 EDT
Volume:7.45K
Turnover:20.93K
Market Cap:4.31M
PE:-1.09
High:2.86
Open:2.83
Low:2.68
Close:2.70
Loading ...
Oct 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2020

Major Issues Report

8-K - Current report
Jun 16, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2020

Major Issues Report

8-K - Current report
Apr 29, 2020

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 24, 2020

Major Issues Report

Current report, item 3.01
Apr 01, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 27, 2020

Major Issues Report

8-K - Current report
Mar 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 21, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 06, 2019

Major Issues Report

Current report, item 5.07
Nov 15, 2019

Major Issues Report

Current report, items 2.02 and 9.01